Injectable · Scalp · Hair Loss

Mesotherapy for Hair

How this page was made

This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full disclaimer for how SHEA creates and reviews treatment information.

What it is

Mesotherapy is a method of delivering substances through multiple small injections into the skin. For hair loss, these injections are made into the scalp.

The important thing to know is that mesotherapy is a delivery technique, not one specific treatment. What is injected can vary substantially. Published studies have investigated substances including dutasteride, minoxidil, growth factors, multivitamin mixtures, botulinum toxin A, stem-cell-related preparations, and other formulations.

Because the ingredients differ, evidence for one form of mesotherapy should not automatically be applied to another. A study of injected dutasteride, for example, does not establish that a vitamin or peptide mixture produces the same effect.

The route of administration matters too. A medication can have evidence or regulatory approval in one form without its intradermal injection being an approved use. In South Korea, oral dutasteride 0.5 mg has been approved for male androgenetic alopecia since 2009. That does not mean injecting dutasteride into the scalp carries the same approval or evidence.

Why people consider it

They have androgenetic alopecia, or pattern hair loss, and are considering an injectable treatment
They have been offered scalp injections containing a medication such as dutasteride or minoxidil and want to understand how the evidence compares with established routes of treatment
They are considering a clinic's vitamin, peptide, or other mesotherapy mixture and want to know what evidence exists for the specific ingredients being injected
They are interested in local delivery but understand that injecting a substance into the scalp does not automatically make it more effective or free of systemic effects

What the experience is like

Mesotherapy involves multiple small injections across the area of the scalp being treated. Injections may be performed manually or with an injection device. The exact technique depends on the product, practitioner, and treatment protocol.

Protocols vary considerably between studies and clinics. The injected substance, concentration, dose, injection depth, spacing, treatment interval, and number of sessions are not standardized across the mesotherapy literature.

Temporary injection-site discomfort, redness, swelling, or other local reactions can occur. The safety profile can also depend on what is being injected, so the risks of one mesotherapy formulation should not automatically be assumed to apply to another.

Limitations & considerations

Ask exactly what is being injected

"Hair mesotherapy" does not identify a specific drug or formula. Published research includes very different injected substances, and their evidence and safety profiles are not interchangeable. Before treatment, find out the exact ingredients, concentrations, and medications in the proposed solution rather than relying on the word "mesotherapy" alone.

There is no standardized mesotherapy formulation or treatment protocol for hair loss across the published literature
The evidence is highly product- and formulation-specific. Results from dutasteride mesotherapy cannot be used as evidence for vitamin, peptide, minoxidil, growth-factor, or other mixtures
In South Korea, oral dutasteride is an approved treatment for male androgenetic alopecia, but intradermal dutasteride mesotherapy is a different route of administration and should be evaluated separately
Evidence for nutrient- and multivitamin-based mixtures is particularly difficult to generalize because formulations differ and the broader mesotherapy literature remains heterogeneous
Mesotherapy can cause adverse effects. Published reports include pain and local reactions as well as less common complications such as marked swelling, infection, tissue injury, and hair loss at injection sites
In a 2022 retrospective study of dutasteride mesotherapy, pain was the most frequently reported adverse effect. The study did not include a randomized control group, so its effectiveness findings should be interpreted accordingly
Whether treatment is appropriate can depend on the medication or other substance being injected, the person's medical history, and the condition causing the hair loss
No specific improvement in hair density or other outcome can be guaranteed

Evidence note

A 2023 systematic review identified 27 studies of mesotherapy for hair loss. The treatments were highly varied and included six broad classes of injected agents or combinations: dutasteride, minoxidil, growth factors or autologous suspensions, botulinum toxin A, stem cells, and multivitamin or other mesotherapy mixtures. Several studies reported improvements, but the authors emphasized the lack of standardized regimens and called for larger controlled trials.

Dutasteride mesotherapy has more direct clinical evidence than many generic mesotherapy mixtures, but that evidence remains specific to dutasteride protocols. A 2022 multicenter retrospective study included 541 patients with androgenetic alopecia treated with dutasteride mesotherapy. Effectiveness of mesotherapy used alone could be assessed in only 86 patients after one year. Most were judged to have improved, but the study was retrospective and uncontrolled. Pain was reported by 45.5% of the full cohort, while no serious or sexual adverse events were detected.

Safety also depends on the injected formulation and technique. A 2022 multicenter case series documented 14 cases of frontal edema following mesotherapy for androgenetic alopecia. The authors also noted previously reported complications including subcutaneous necrosis, scalp abscesses, and angioedema. Case reports and case series can identify possible complications but cannot establish how frequently they occur.

A 2024 systematic review comparing mesotherapy approaches with topical minoxidil concluded that the existing literature suggests possible benefit but remains insufficient to establish an optimal mesotherapy treatment. The authors called for larger studies to determine efficacy and safety. They declared no competing interests.

References

Peer-reviewed literature and Korean regulatory context.

1. Gupta AK, Polla Ravi S, Wang T, Talukder M, Starace M, Piraccini BM. Systematic review of mesotherapy: a novel avenue for the treatment of hair loss. Journal of Dermatological Treatment, 2023;34(1):2245084.

Peer-reviewed · Systematic review · 27 studies · Multiple different injected agents

2. Saceda-Corralo D, Moustafa F, Moreno-Arrones Ó, Jaén-Olasolo P, Vañó-Galván S, Camacho F. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice. Journal of Drugs in Dermatology, 2022;21(7):742–747.

Peer-reviewed · Multicenter retrospective study · n=541 · Dutasteride-specific

3. Melo DF, Saceda-Corralo D, Tosti A, et al. Frontal edema due to mesotherapy for androgenetic alopecia: a case series. Dermatologic Therapy, 2022;35(2):e15247.

Peer-reviewed · Case series · 14 cases · Safety signal

4. Aledani EM, Kaur H, Kasapoglu M, Yadavalli R, Nawaz S, Althwanay A, Nath TS. Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review. Cureus, 2024;16(5):e59705.

Peer-reviewed · Systematic review · Authors declared no competing interests

5. Choi S, Kwon S-H, Sim W-Y, Lew B-L. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. Journal of Dermatology, 2024;51(5):684–690.

Peer-reviewed · Korean regulatory context · Oral dutasteride approved for male AGA in Korea since 2009